IRGM
Basic information
Region (hg38): 5:150846521-150900736
Previous symbols: [ "IRGM1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IRGM gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 14 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 26 | 31 | ||||
Total | 0 | 0 | 40 | 4 | 5 |
Variants in IRGM
This is a list of pathogenic ClinVar variants found in the IRGM region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-150848136-A-C | not specified | Uncertain significance (Sep 16, 2021) | ||
5-150848149-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
5-150848207-A-G | not specified | Uncertain significance (Sep 16, 2021) | ||
5-150848235-A-G | not specified | Likely benign (Sep 16, 2021) | ||
5-150848275-G-A | not specified | Uncertain significance (Feb 13, 2023) | ||
5-150848356-A-G | not specified | Uncertain significance (Oct 26, 2021) | ||
5-150848397-C-T | not specified | Uncertain significance (Mar 23, 2022) | ||
5-150848398-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
5-150848408-G-A | IRGM-related disorder | Likely benign (May 01, 2022) | ||
5-150848416-C-G | not specified | Uncertain significance (Apr 15, 2024) | ||
5-150848422-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
5-150848436-C-T | Inflammatory bowel disease 19 • not specified | Benign (Apr 04, 2024) | ||
5-150848457-C-T | not specified | Uncertain significance (Sep 14, 2022) | ||
5-150848502-C-G | not specified | Uncertain significance (Jan 03, 2024) | ||
5-150848502-C-T | not specified | Uncertain significance (Jul 16, 2021) | ||
5-150848511-C-T | not specified | Uncertain significance (Apr 07, 2023) | ||
5-150848517-A-G | not specified | Uncertain significance (Mar 28, 2023) | ||
5-150848520-A-G | Uncertain significance (-) | |||
5-150848534-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
5-150848587-G-A | not specified | Uncertain significance (Jan 10, 2023) | ||
5-150848653-G-A | not specified | Likely benign (Jan 18, 2022) | ||
5-150879654-T-C | IRGM-related disorder | Likely benign (Dec 01, 2022) | ||
5-150895582-C-T | not specified | Uncertain significance (Dec 13, 2021) | ||
5-150895617-C-T | not specified | Uncertain significance (Dec 31, 2023) | ||
5-150895664-T-G | not specified | Uncertain significance (May 09, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IRGM | protein_coding | protein_coding | ENST00000522154 | 1 | 54214 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.414 | 84 | 95.4 | 0.881 | 0.00000447 | 1190 |
Missense in Polyphen | 17 | 20.312 | 0.83695 | 294 | ||
Synonymous | 0.132 | 34 | 35.0 | 0.972 | 0.00000156 | 361 |
Loss of Function |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | ||
East Asian | ||
Finnish | ||
European (Non-Finnish) | ||
Middle Eastern | ||
South Asian | ||
Other |
dbNSFP
Source:
- Function
- FUNCTION: Putative GTPase which is required for clearance of acute protozoan and bacterial infections. Functions in innate immune response probably through regulation of autophagy. May regulate proinflammatory cytokine production and prevent endotoxemia upon infection. May also play a role in macrophages adhesion and motility (By similarity). {ECO:0000250, ECO:0000269|PubMed:16888103}.;
- Disease
- DISEASE: Inflammatory bowel disease 19 (IBD19) [MIM:612278]: A chronic, relapsing inflammation of the gastrointestinal tract with a complex etiology. It is subdivided into Crohn disease and ulcerative colitis phenotypes. Crohn disease may affect any part of the gastrointestinal tract from the mouth to the anus, but most frequently it involves the terminal ileum and colon. Bowel inflammation is transmural and discontinuous; it may contain granulomas or be associated with intestinal or perianal fistulas. In contrast, in ulcerative colitis, the inflammation is continuous and limited to rectal and colonic mucosal layers; fistulas and granulomas are not observed. Both diseases include extraintestinal inflammation of the skin, eyes, or joints. {ECO:0000269|PubMed:17554261, ECO:0000269|PubMed:19174780, ECO:0000269|PubMed:21278745}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- Toxoplasmosis - Homo sapiens (human)
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.57
- rvis_percentile_EVS
- 81.78
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.165
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Irgm2
- Phenotype
Gene ontology
- Biological process
- autophagosome assembly;positive regulation of protein phosphorylation;defense response;inflammatory response;positive regulation of autophagy;positive regulation of peptidyl-threonine phosphorylation;protein destabilization;positive regulation of peptidyl-serine phosphorylation;cellular response to interferon-beta;defense response to bacterium;regulation of protein complex assembly;innate immune response;protein stabilization;defense response to Gram-negative bacterium;positive regulation of interferon-gamma-mediated signaling pathway;regulation of protein complex stability;protein lipidation involved in autophagosome assembly;CAMKK-AMPK signaling cascade;nucleotide-binding oligomerization domain containing 2 signaling pathway;cellular response to lipopolysaccharide;positive regulation of protein serine/threonine kinase activity;autophagy of host cells involved in interaction with symbiont;cellular response to virus;positive regulation of autophagosome maturation
- Cellular component
- Golgi membrane;autophagosome membrane;phagocytic cup;mitochondrion;endoplasmic reticulum membrane;Golgi apparatus;cytosol;phagocytic vesicle membrane;cell projection
- Molecular function
- GTPase activity;protein binding;GTP binding;protein kinase binding;protein serine/threonine kinase activator activity;CARD domain binding;BH3 domain binding